Abbott announces effectiveness of AbbVie separation Abbott announced that the SEC has declared effective the Form 10 registration statement filed by AbbVie, its research-based pharmaceuticals business. Abbott expects to complete the separation of AbbVie on Jan. 1, 2013. On Nov. 28, Abbott's board approved the separation of AbbVie, and declared a special dividend distribution of one share of AbbVie common stock for each Abbott common share outstanding as of the close of business on Dec. 12, the record date for the distribution. Abbott expects the special dividend of AbbVie stock will be distributed on Jan. 1, 2013. :theflyonthewall.com
News For ABT From The Last 14 Days
Check below for free stories on ABT the last two weeks.